Language:

Consensus care recommendations for alfapump ® in cirrhotic patients with refractory or recurrent ascites

BMC gastroenterology, 2022-03, Vol.22 (1), p.111-111, Article 111 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-230X ;EISSN: 1471-230X ;DOI: 10.1186/s12876-022-02173-5 ;PMID: 35260086

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Consensus care recommendations for alfapump ® in cirrhotic patients with refractory or recurrent ascites
Author: Aagaard, Niels Kristian ; Malago, Massimo ; De Gottardi, Andrea ; Thomas, Michael ; Sauter, Gerd ; Engelmann, Cornelius ; Aranovich, David ; Cohen, Michal ; Thévenot, Thierry ; Ehmann, Thomas ; Capel, Jeroen ; Angeli, Paolo ; Jalan, Rajiv ; Stirnimann, Guido
Subjects: Alfapump ; Analysis ; Ascites ; Ascites - etiology ; Ascites - therapy ; Cirrhosis ; Complications and side effects ; Diuretics ; Dosage and administration ; Health aspects ; Humans ; Implants, Artificial ; Liver Cirrhosis - complications ; Liver Cirrhosis - surgery ; Liver diseases ; Paracentesis ; Prosthesis ; Refractory ascites ; TIPSS ; Urinary Bladder
Is Part Of: BMC gastroenterology, 2022-03, Vol.22 (1), p.111-111, Article 111
Description: The alfapump is an implantable class III medical device that pumps ascitic fluid from the peritoneal space to the urinary bladder from where it is excreted. The pump reduces or abrogates the need for repeated paracentesis in patients with recurrent or refractory ascites. To improve outcomes for alfapump implantation and pre- and post-implant patient management in both clinical trial and real-world settings by development of consensus recommendations. The alfapump working group consisting of hepatologists and surgeons with extensive experience in implantation of the alfapump and patient management met on two occasions: (1) to determine the key areas where recommendations should be made; and (2) to discuss the experiences of the working group within those areas and formulate draft statements. Developed statements were submitted to the group and consensus sought on relevance and wording through a collaborative iterative approach in order to consolidate the recommendations into consensus statements. Only recommendations agreed upon unanimously were included. Twenty-three consensus recommendations were developed in the areas of pre-implantation procedure, (three statements), surgical implant procedure (11 statements), immediate post-implant care (three statements) and long-term management (six statements). The consensus statements are a valuable reference resource for physicians managing patients with the alfapump and for those considering management strategies for patients with refractory ascites.
Publisher: England: BioMed Central Ltd
Language: English
Identifier: ISSN: 1471-230X
EISSN: 1471-230X
DOI: 10.1186/s12876-022-02173-5
PMID: 35260086
Source: GFMER Free Medical Journals
MEDLINE
PubMed Central
Springer Nature OA/Free Journals
ROAD: Directory of Open Access Scholarly Resources
ProQuest Central
DOAJ Directory of Open Access Journals

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Consensus care recommendations for alfapump ® in cirrhotic patients with refractory or recurrent ascites

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-230X ;EISSN: 1471-230X ;DOI: 10.1186/s12876-022-02173-5 ;PMID: 35260086

Searching Remote Databases, Please Wait